This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2011-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ewing, NJ (US) (2011)
- Secaucus, NJ (US) (2014 - 2016)
Company Filing History:
Years Active: 2011-2016
Title: The Innovative Contributions of Joel Francis Austin
Introduction
Joel Francis Austin is a notable inventor based in Secaucus, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific enzymes associated with cancer treatment. With a total of 4 patents to his name, Austin's work is recognized for its potential impact on medical therapies.
Latest Patents
Austin's latest patents include innovative compounds that have shown promise in treating conditions related to the CYP17 enzyme. One of his patents focuses on substituted azaindazole compounds, which are disclosed as having the potential to treat various CYP17 associated conditions, including cancer. The compounds are characterized by specific structural formulas and include methods for their use in pharmaceutical compositions. Another patent details sulfonamide compounds that serve as CYP17 inhibitors, also aimed at treating cancer and related conditions. These compounds are described in terms of their chemical structure and potential therapeutic applications.
Career Highlights
Austin is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work there has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry. His innovative approach and dedication to improving patient outcomes through targeted therapies have made him a valuable asset to his team.
Collaborations
Throughout his career, Austin has collaborated with several esteemed colleagues, including Mark George Saulnier and James Aaron Balog. These collaborations have fostered a productive environment for innovation and have led to the advancement of several key projects in the field.
Conclusion
Joel Francis Austin's contributions to pharmaceutical innovation are noteworthy, particularly in the development of compounds aimed at treating cancer. His work at Bristol-Myers Squibb Company and his collaborations with other professionals highlight his commitment to advancing medical science. Austin's patents reflect a promising future for targeted therapies in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile